IP Library › Granted Patent US 10,253,254
Granted Patent B2
US 10,253,254 · App. 15/490,714 · Granted Apr 9, 2019

Substituted benzo[f]imidazo[1,2-a]quinoxalines

Inventors: Bruce Bryan (Beverly Hills, CA); Hendrik Schmidt (Denver, CO); Millard Cull (Brighton, CO)
Assignee: PROLUME, LTD.
C09K11/07A61K38/1767A61K38/44A61K49/0045A63J5/02C07D487/04C12N9/0069C12Y113/12007C09K2211/1007C09K2211/1018C09K2211/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,253,254
App. No.
15/490,714
Granted
Apr 9, 2019
Kind
B2
Abstract

The disclosure comprises novel Coelenterazine compounds and methods of use, including a simple delivery device for the photoprotein to create effects by their luminous reaction upon contact with surfaces that contain calcium. Calcium is ubiquitous in and on most surfaces and in the environment; it is this unique property of calcium that makes this a novel use of the photoproteins for entertainment. A base coelenterazine structure is depicted below.

Claims (4)

1. A compound represented by the formula:

wherein:

R 1 is —OCH 3 ; and

R 2 is —OH.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2017
From: BRYAN, BRUCE; SCHMIDT, HENDRIK; CULL, MILLARD
To: PROLUME, LTD.
Reel/Frame 042282/0263 →
Continuity (3)
Continuation 14424969
Provisional Application 61696136 · Sep 1, 2012
Related Publication 20170217969A1 · Aug 3, 2017